{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1029.125","meta":{"versionId":"12","lastUpdated":"2020-10-21T01:02:49.000-04:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>Maternal Drug Use</h2>\n      <p>This value set includes codes from the following code systems:</p>\n      <ul>\n        <li>Include these codes as defined in \n          <code>http://hl7.org/fhir/sid/icd-10-cm</code>\n          <table class=\"none\">\n            <tr>\n              <td>\n                <b>Code</b>\n              </td>\n              <td>\n                <b>Display</b>\n              </td>\n            </tr>\n            <tr>\n              <td>P04.11</td>\n              <td>Newborn affected by maternal antineoplastic chemotherapy</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>P04.12</td>\n              <td>Newborn affected by maternal cytotoxic drugs</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>P04.13</td>\n              <td>Newborn affected by maternal use of anticonvulsants</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>P04.14</td>\n              <td>Newborn affected by maternal use of opiates</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>P04.15</td>\n              <td>Newborn affected by maternal use of antidepressants</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>P04.16</td>\n              <td>Newborn affected by maternal use of amphetamines</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>P04.17</td>\n              <td>Newborn affected by maternal use of sedative-hypnotics</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>P04.18</td>\n              <td>Newborn affected by other maternal medication</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>P04.19</td>\n              <td>Newborn affected by maternal use of unspecified medication</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>P04.1A</td>\n              <td>Newborn affected by maternal use of anxiolytics</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>P04.3</td>\n              <td>Newborn affected by maternal use of alcohol</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>P04.40</td>\n              <td>Newborn affected by maternal use of unspecified drugs of addiction</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>P04.41</td>\n              <td>Newborn affected by maternal use of cocaine</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>P04.42</td>\n              <td>Newborn affected by maternal use of hallucinogens</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>P04.49</td>\n              <td>Newborn affected by maternal use of other drugs of addiction</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>P04.81</td>\n              <td>Newborn affected by maternal use of cannabis</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>P04.89</td>\n              <td>Newborn affected by other maternal noxious substances</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>P96.1</td>\n              <td>Neonatal withdrawal symptoms from maternal use of drugs of addiction</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>P96.2</td>\n              <td>Withdrawal symptoms from therapeutic use of drugs in newborn</td>\n              <td/>\n            </tr>\n          </table>\n        </li>\n      </ul>\n    </div>"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.125","version":"20201021","name":"Maternal Drug Use","status":"active","date":"2020-10-21T01:02:49-04:00","publisher":"Joint Commission","compose":{"include":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","concept":[{"code":"P04.11","display":"Newborn affected by maternal antineoplastic chemotherapy"},{"code":"P04.12","display":"Newborn affected by maternal cytotoxic drugs"},{"code":"P04.13","display":"Newborn affected by maternal use of anticonvulsants"},{"code":"P04.14","display":"Newborn affected by maternal use of opiates"},{"code":"P04.15","display":"Newborn affected by maternal use of antidepressants"},{"code":"P04.16","display":"Newborn affected by maternal use of amphetamines"},{"code":"P04.17","display":"Newborn affected by maternal use of sedative-hypnotics"},{"code":"P04.18","display":"Newborn affected by other maternal medication"},{"code":"P04.19","display":"Newborn affected by maternal use of unspecified medication"},{"code":"P04.1A","display":"Newborn affected by maternal use of anxiolytics"},{"code":"P04.3","display":"Newborn affected by maternal use of alcohol"},{"code":"P04.40","display":"Newborn affected by maternal use of unspecified drugs of addiction"},{"code":"P04.41","display":"Newborn affected by maternal use of cocaine"},{"code":"P04.42","display":"Newborn affected by maternal use of hallucinogens"},{"code":"P04.49","display":"Newborn affected by maternal use of other drugs of addiction"},{"code":"P04.81","display":"Newborn affected by maternal use of cannabis"},{"code":"P04.89","display":"Newborn affected by other maternal noxious substances"},{"code":"P96.1","display":"Neonatal withdrawal symptoms from maternal use of drugs of addiction"},{"code":"P96.2","display":"Withdrawal symptoms from therapeutic use of drugs in newborn"}]}]}}